Filtreeri Last updated date SelectPärastEnneFrom - To Date Lõppkuupäev This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Tulemused (3838) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank Committee for veterinary medicinal products: Meeting of 22 to 24 July 2003 25 juuli 2003Press releaseVeterinary European Agency for the evaluation of medicinal products: Committee for Proprietary Medicinal Products, meeting of 22 to 24 July 2003 25 juuli 2003Press release 37th meeting of the Committee for Orphan Medicinal Products 13 juuli 2003Press releaseHumanRare diseases Meeting of the EMEA working party on herbal medicinal products 30 June - 1 July 2003 9 juuli 2003Press releaseHerbal European Agency for the evaluation of medicinal products: Committee for Proprietary Medicinal Products, meeting of 24 to 26 June 2003 27 juuni 2003Press release Committee for veterinary medicinal products: Meeting of 17 to 19 June 2003 20 juuni 2003Press releaseVeterinary 36th meeting of the Committee for Orphan Medicinal Products 16 juuni 2003Press releaseHumanRare diseases EMEA Management Board adopts fee implementing rule and looks at the Agency's corporate governance 9 juuni 2003Press releaseCorporate EMEA public statement on Refacto (moroctocog alfa): Introduction of a change to Refacto drug product specific activity specification increase of 20% in the amount of Refacto protein in each vial 27 Mai 2003News European Agency for the evaluation of medicinal products: Committee for Proprietary Medicinal Products, meeting of 20 to 22 May 2003 22 Mai 2003Press release 1 … 349 350 351 352 353 Page 353 of 384 354 355 356 357 … 384
Committee for veterinary medicinal products: Meeting of 22 to 24 July 2003 25 juuli 2003Press releaseVeterinary
European Agency for the evaluation of medicinal products: Committee for Proprietary Medicinal Products, meeting of 22 to 24 July 2003 25 juuli 2003Press release
37th meeting of the Committee for Orphan Medicinal Products 13 juuli 2003Press releaseHumanRare diseases
Meeting of the EMEA working party on herbal medicinal products 30 June - 1 July 2003 9 juuli 2003Press releaseHerbal
European Agency for the evaluation of medicinal products: Committee for Proprietary Medicinal Products, meeting of 24 to 26 June 2003 27 juuni 2003Press release
Committee for veterinary medicinal products: Meeting of 17 to 19 June 2003 20 juuni 2003Press releaseVeterinary
36th meeting of the Committee for Orphan Medicinal Products 16 juuni 2003Press releaseHumanRare diseases
EMEA Management Board adopts fee implementing rule and looks at the Agency's corporate governance 9 juuni 2003Press releaseCorporate
EMEA public statement on Refacto (moroctocog alfa): Introduction of a change to Refacto drug product specific activity specification increase of 20% in the amount of Refacto protein in each vial 27 Mai 2003News
European Agency for the evaluation of medicinal products: Committee for Proprietary Medicinal Products, meeting of 20 to 22 May 2003 22 Mai 2003Press release